UNSPSC 85252101: Diagnosis of malignant neoplasm on the nipple and areola

This classification denotes the group of activities that yields a diagnosis of Malignant neoplasm on the Nipple and areola. Malignant neoplasm on the Nipple and areola is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code C50. 0

UNSPSC 85252101 Diagnosis of malignant neoplasm on the nipple and areola is a Commodity code that shows minimal alignment between its clinical nomenclature and the state and local procurement activity currently tagged to it. The recent solicitations do not request diagnostic services, clinical evaluations, or pathology work related to breast cancer screening or diagnosis. Instead, the tagged opportunities span diagnostic imaging infrastructure (PACS systems), special education contracted services (speech therapy, occupational therapy, audiology), and temporary health professional staffing across ancillary clinical categories including audiology, diagnostic imaging, and therapy services. The code's nominal scope—a specific malignant neoplasm diagnosis—does not match the scope of work actually being solicited under this code tag in the current market.

State and local issuing bodies posting under this code include public hospital systems (San Mateo Medical Center), independent school districts (Birdville ISD, Texas), and county health systems (Santa Clara County Health System). Geographic activity spans California and Texas in the recent block. Representative recent opportunities include San Mateo Medical Center's RFP for Diagnostic Imaging PACS implementation with a response date of October 21, 2026, and the County of Santa Clara Health System's RFQ to establish a qualified vendor pool for temporary health professional staffing (audiology, diagnostic imaging/radiology, therapy services, and others) with a response date of October 7, 2026. The mismatch between code nomenclature and procurement activity suggests either a tagging error by the issuing bodies or that this code does not reliably identify relevant state and local contracting opportunities in its intended clinical domain.